CAJ | 학술논문

自发现人类免疫缺陷病毒1型（HIV-1）30年来，科学家们不断探索有效的 HIV-1疫苗，但至今效果不理想。由于“精英患者”的广谱中和血清能起到有效的抗病毒作用，研究人员希望通过对体液保护免疫机制的研究，推动疫苗的设计和优化，为尽早研发成功 HIV疫苗提供关键理论和技术支撑。近几年来，由于技术的突破和改进，从HIV感染者中分离获得广谱中和抗体的概率和数量大大提高。本文针对近几年来分离的有代表性的广谱中和抗体，根据其不同的识别位点分为四大类进行详细介绍，并总结了从研究广谱中和抗体中所获得的疫苗设计创新思路与启示。
자발현인류면역결함병독1형（HIV-1）30년래，과학가문불단탐색유효적 HIV-1역묘，단지금효과불이상。유우“정영환자”적엄보중화혈청능기도유효적항병독작용，연구인원희망통과대체액보호면역궤제적연구，추동역묘적설계화우화，위진조연발성공 HIV역묘제공관건이론화기술지탱。근궤년래，유우기술적돌파화개진，종HIV감염자중분리획득엄보중화항체적개솔화수량대대제고。본문침대근궤년래분리적유대표성적엄보중화항체，근거기불동적식별위점분위사대류진행상세개소，병총결료종연구엄보중화항체중소획득적역묘설계창신사로여계시。
Antibody response is a crucial host defense against human immunodeficiency virus type 1 (HIV-1) infection .In recent years , tremendous progress has been made in isolating and characterizing of broadly neutralizing monoclonal antibodies (bnmAbs ) from “elite neutralizers” who remain healthy despite of prolonged infection . These bnmAbs were found to target four major vulnerable sites on the envelope glycoprotein .Structural and functional characterization of these bnmAbs has provided critical foundation for our better understanding of protective antibody response in vivo .In the current review ,we summarize the characteristics of these bnmAbs and discuss on their implications for rational design of novel HIV-1 vaccines capable of inducing antibodies similar to those bnmAbs .